Skip to main content
Clinical Trials/NCT06372600
NCT06372600UnknownNot Applicable

Effect of Extracorporeal Shock Wave Combined With Autologous Platelet-rich Plasma Injection on Rotator Cuff Calcific Tendinitis: A Randomized Controlled Trial

Xiali Xue0 sites60 target enrollmentStarted: June 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Primary Endpoint
Visual Analogue Scale,VAS

Study Overview

Brief Summary

The purpose of this study is to explore the effect of extracorporeal shock wave combined with autologous platelet-rich plasma injection on the rehabilitation of rotator cuff calcific tendinitis, to provide new treatment methods and evidence for the rehabilitation of rotator cuff calcific tendinitis, and to reduce patients; pain and return to normal life as soon as possible.

Detailed Description

The purpose of this study is to explore the effect of extracorporeal shock wave combined with autologous platelet-rich plasma injection on the rehabilitation of rotator cuff calcific tendinitis, to provide new treatment methods and evidence for the rehabilitation of rotator cuff calcific tendinitis, and to reduce patients' pain and return to normal life as soon as possible.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Meet the diagnostic criteria for rotator cuff calcific tendonitis, aged between 40 and 60 years old
  • Persistent pain in the affected shoulder, with obvious tenderness under the acromion and rotator cuff, as confirmed by X-ray and Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) examination showed one or more round-shaped high-density calcium salt deposits near the greater tuberosity of the humerus
  • All were diagnosed for the first time
  • Complaints of severe pain in the shoulder joint, obvious

Exclusion Criteria

  • Combined with rotator cuff trauma, long head of biceps tendonitis and other shoulder joint diseases
  • Past combined history of shoulder joint surgery
  • Patients with internal fixation of the shoulder joint
  • Shoulder joint combined with infection, Tumors and other lesions
  • Combined with severe heart, liver, and kidney dysfunction
  • Do not agree to participate in the study or fail to sign the informed consent form.

Outcomes

Primary Outcomes

Visual Analogue Scale,VAS

Time Frame: After 1, 2, 4 and 8 weeks of intervention

The full name of the Scale is Visual Analogue Scale, that is, visual analogue scale. Minimum value and maximum value: the minimum value of the VAS scale is 0, indicating "completely painless" or "painless end"; The maximum value is 10, which indicates "the most severe pain imaginable" or "the most severe pain end." Score Significance: On the VAS scale, a higher score means a worse outcome, i.e. a greater degree of pain. The patient marks the corresponding position on the scale according to their pain experience, thus indicating the intensity of the pain.

Secondary Outcomes

  • the university of California at Los Angeles shoulder rating scale, UCLA(After 1, 2, 4 and 8 weeks of intervention)
  • American Shoulder and Elbow Surgeon's Form,ASES(After 1, 2, 4 and 8 weeks of intervention)
  • The location and size of the calcifications were examined by ultrasound(After 4 and 8 weeks of intervention)

Investigators

Sponsor
Xiali Xue
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Xiali Xue

Clinical Professor

Chengdu Sport University

Similar Trials